Saab Mathew A, Raetz Emily L, Lowe Joshua B, Hudson Ian L, Jacobson Eric J, Long Adrianna N, Achay Jennifer A, Bolleter Scotty D, McCuller Christopher A, Rayas Emmanuel G, Nunnery Alexander M, Bierle Ryan P, Rahm Stephen J, Epley Emily A, Poe Richard J, DeSoucy Erik S, De Lorenzo Robert A, Dumas Ryan P, Paxton James H, Rogerson Tania C, Georgoff Patrick E, Adema Anne L, Eng Hock Ong Marcus, Wampler David A
University of Texas Health Science Center San Antonio, 4502 Medical Dr, San Antonio, TX 78229, USA.
Brooke Army Medical Center, 3551 Roger Brooke Dr. San Antonio, TX 78234, USA.
Resusc Plus. 2024 Jul 16;19:100714. doi: 10.1016/j.resplu.2024.100714. eCollection 2024 Sep.
Obtaining intravenous access in hypotensive patients is challenging and may critically delay resuscitation. The Graduated Vascular Access for Hypotensive Patient (GAHP) protocol leverages intraosseous fluid boluses to specifically dilate proximal veins. This study aims to evaluate the efficacy of GAHP in maximizing venous targets through early distal intraosseous access and a small fluid bolus.
This was a prospective randomized cadaveric pilot study to evaluate extremity venous engorgement during intraosseous infusion. Cadavers (n = 23) had an intraosseous needle inserted into four sites: distal radius, proximal humerus, distal femur, and distal tibia. Intraosseous saline was rapidly infused, venous optimization was measured using real-time ultrasound. Primary outcome was maximum vessel circumference increase with intraosseous infusion. Secondary outcomes were: time to maximum circumference, and infusion volume required. Statistical analyses included Levene's test for equality of variances, Wilcoxon signed-rank test, and generalized estimating equation.
There was a significant mean increase of 1.03 cm (95% CI 0.86, 1.20), representing a difference of 102%. We found no significant difference in time to optimize vessel circumference across sites, but volume required significantly differed.
GAHP quickly and effectively increased the circumference of anatomically adjacent veins. Anatomical sites did not differ on time to reach maximum enlargement of vessels following intraosseous infusion but did differ in terms of volume required to maximize vessel circumference. Further research is needed using live, hypotensive patients.
在低血压患者中建立静脉通路具有挑战性,可能会严重延误复苏。低血压患者分级血管通路(GAHP)方案利用骨内液体推注来特异性扩张近端静脉。本研究旨在评估GAHP通过早期远端骨内通路和小剂量液体推注在最大化静脉目标方面的疗效。
这是一项前瞻性随机尸体试验研究,旨在评估骨内输注期间肢体静脉充血情况。尸体(n = 23)在四个部位插入骨内针:桡骨远端、肱骨近端、股骨远端和胫骨远端。快速输注骨内生理盐水,使用实时超声测量静脉优化情况。主要结局是骨内输注时血管最大周长增加。次要结局包括:达到最大周长的时间,以及所需输注量。统计分析包括方差齐性的Levene检验、Wilcoxon符号秩检验和广义估计方程。
平均显著增加1.03 cm(95%CI 0.86,1.20),差异为102%。我们发现各部位优化血管周长的时间没有显著差异,但所需输注量有显著差异。
GAHP快速有效地增加了解剖学相邻静脉的周长。骨内输注后,各解剖部位达到血管最大扩张的时间没有差异,但在使血管周长最大化所需的输注量方面存在差异。需要使用低血压活体患者进行进一步研究。